Churchill Pharmaceuticals is focused on developing and delivering valued therapies that improve trusted pharmaceuticals for patients living with cancer. We are a rapidly growing, privately funded company based in the greater Philadelphia area. Our lead product is for treatment of genitourinary cancers. Our pipeline includes other oral cancer compounds which utilize the SoluMatrix Fine Particle Technology® to improve patient outcomes focusing on efficacy, predictability, and/or safety performance.